Literature DB >> 33608234

How Should Molecular Markers and Magnetic Resonance Imaging Be Used in the Early Detection of Prostate Cancer?

Andrew J Vickers1, Giorgio Russo2, Hans Lilja3, Christopher Evans4, Jack A Schalken5, Eric Klein6, Scott Eggener7.   

Abstract

The literature gives limited data or guidance on how to select or combine biomarkers and magnetic resonance imaging (MRI) for the early detection of prostate cancer. We strongly recommend prospective studies large enough to address questions such as the properties of biomarkers in cases with high versus low Prostate Imaging-Reporting and Data System scores or the correlation between biomarkers and MRI, and that evaluate results in the context of reasonable clinical scenarios.
Copyright © 2021 European Association of Urology. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33608234     DOI： 10.1016/j.euo.2021.01.010

Source DB:  PubMed          Journal:  Eur Urol Oncol        ISSN： 2588-9311


  5 in total

1.  External Validation of the Prostate Biopsy Collaborative Group Risk Calculator and the Rotterdam Prostate Cancer Risk Calculator in a Swedish Population-based Screening Cohort.

Authors:  Jan Chandra Engel; Thorgerdur Palsdottir; Donna Ankerst; Sebastiaan Remmers; Ashkan Mortezavi; Venkatesh Chellappa; Lars Egevad; Henrik Grönberg; Martin Eklund; Tobias Nordström
Journal:  Eur Urol Open Sci       Date:  2022-05-19

2.  Comparative Analysis of PSA Density and an MRI-Based Predictive Model to Improve the Selection of Candidates for Prostate Biopsy.

Authors:  Juan Morote; Angel Borque-Fernando; Marina Triquell; Anna Celma; Lucas Regis; Richard Mast; Inés M de Torres; María E Semidey; José M Abascal; Pol Servian; Anna Santamaría; Jacques Planas; Luis M Esteban; Enrique Trilla
Journal:  Cancers (Basel)       Date:  2022-05-11       Impact factor: 6.575

3.  Improving the Early Detection of Clinically Significant Prostate Cancer in Men in the Challenging Prostate Imaging-Reporting and Data System 3 Category.

Authors:  Juan Morote; Miriam Campistol; Marina Triquell; Anna Celma; Lucas Regis; Inés de Torres; Maria E Semidey; Richard Mast; Anna Santamaria; Jacques Planas; Enrique Trilla
Journal:  Eur Urol Open Sci       Date:  2022-01-23

4.  The Efficacy of Proclarix to Select Appropriate Candidates for Magnetic Resonance Imaging and Derived Prostate Biopsies in Men with Suspected Prostate Cancer.

Authors:  Juan Morote; Miriam Campistol; Anna Celma; Lucas Regis; Inés de Torres; María E Semidey; Sarai Roche; Richard Mast; Anna Santamaría; Jacques Planas; Enrique Trilla
Journal:  World J Mens Health       Date:  2021-12-27       Impact factor: 5.400

5.  Urinary symptoms and prostate cancer-the misconception that may be preventing earlier presentation and better survival outcomes.

Authors:  Vincent J Gnanapragasam; David Greenberg; Neil Burnet
Journal:  BMC Med       Date:  2022-08-04       Impact factor: 11.150
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.